These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 17256452)

  • 21. Ciprofloxacin and norfloxacin pharmacokinetics and prostatic fluid penetration in dogs after multiple oral dosing.
    Albarellos GA; Montoya L; Waxman S; Kreil V; Ambros LA; Hallu R; Rebuelto M
    Vet J; 2006 Sep; 172(2):334-9. PubMed ID: 15994101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of pharmacokinetic interaction between linezolid and antacid in healthy volunteers.
    Grunder G; Zysset-Aschmann Y; Vollenweider F; Maier T; Krähenbühl S; Drewe J
    Antimicrob Agents Chemother; 2006 Jan; 50(1):68-72. PubMed ID: 16377669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects on cimetidine bioavailability of metoclopramide and antacids given two hours apart.
    Barzaghi N; Crema F; Mescoli G; Perucca E
    Eur J Clin Pharmacol; 1989; 37(4):409-10. PubMed ID: 2598975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Update on quinolone drug interactions.
    Hulisz D; Miller K
    Am Pharm; 1990 Sep; NS30(9):34-6. PubMed ID: 2220561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A multiple-dose pharmacokinetic interaction study between didanosine (Videx) and ciprofloxacin (Cipro) in male subjects seropositive for HIV but asymptomatic.
    Knupp CA; Barbhaiya RH
    Biopharm Drug Dispos; 1997 Jan; 18(1):65-77. PubMed ID: 9008270
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of antacid administrations on aspirin absorption in patients with chronic renal failure on maintenance hemodialysis.
    Gaspari F; Viganò G; Locatelli M; Remuzzi G
    Am J Kidney Dis; 1988 Apr; 11(4):338-42. PubMed ID: 3354570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urinary excretion of aluminium after ingestion of sucralfate and an aluminium-containing antacid in man.
    Haram EM; Weberg R; Berstad A
    Scand J Gastroenterol; 1987 Jun; 22(5):615-8. PubMed ID: 3629187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Drug interactions between nonsteroidal anti-inflammatory drug and pazufloxacin mesilate, a new quinolone antibacterial agent for intravenous use: convulsions in mice after intravenous or intracerebroventricular administration].
    Fukuda H; Kawamura Y
    Jpn J Antibiot; 2002 Jun; 55(3):270-80. PubMed ID: 12199111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The pharmacokinetics and tissue penetration of the fluoroquinolones.
    Bergeron MG
    Clin Invest Med; 1989 Feb; 12(1):20-7. PubMed ID: 2920479
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative pharmacokinetics of ciprofloxacin and temafloxacin in humans: a review.
    Sorgel F; Naber KG; Kinzig M; Mahr G; Muth P
    Am J Med; 1991 Dec; 91(6A):51S-66S. PubMed ID: 1662896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Sucralfate on the Relative Bioavailability of Enrofloxacin and Ciprofloxacin in Healthy Fed Dogs.
    KuKanich K; KuKanich B; Guess S; Heinrich E
    J Vet Intern Med; 2016; 30(1):108-15. PubMed ID: 26651022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H; Hayakawa I; Akimoto T
    Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of the antacid Maalox on the pharmacokinetics of capecitabine in cancer patients.
    Reigner B; Clive S; Cassidy J; Jodrell D; Schulz R; Goggin T; Banken L; Roos B; Utoh M; Mulligan T; Weidekamm E
    Cancer Chemother Pharmacol; 1999; 43(4):309-15. PubMed ID: 10071982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative pharmacokinetic profiles of two norfloxacin formulations after oral administration in rabbits.
    Park SC; Yun HI; Oh TK
    J Vet Med Sci; 1998 May; 60(5):661-3. PubMed ID: 9637308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of antacid and ranitidine on droxicam pharmacokinetics.
    Bartlett A; Costa A; Martínez L; Roser R; Sagarra R; Sánchez J
    J Clin Pharmacol; 1992 Dec; 32(12):1115-9. PubMed ID: 1487550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fluoroquinolones: interaction profile during enteral absorption.
    Deppermann KM; Lode H
    Drugs; 1993; 45 Suppl 3():65-72. PubMed ID: 7689454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Absorption of ciprofloxacin and norfloxacin when administered as niosome-encapsulated inclusion complexes.
    D'Souza SA; Ray J; Pandey S; Udupa N
    J Pharm Pharmacol; 1997 Feb; 49(2):145-9. PubMed ID: 9055185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of staggered dosing of sucralfate on oral bioavailability of sparfloxacin.
    Kamberi M; Nakashima H; Ogawa K; Oda N; Nakano S
    Br J Clin Pharmacol; 2000 Feb; 49(2):98-103. PubMed ID: 10671902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative study of permeability into rat cerebrospinal fluid of the quinolones: dependency on their lipophilicities.
    Ichikawa N; Naora K; Iwamoto K
    Biol Pharm Bull; 1994 Jan; 17(1):152-5. PubMed ID: 8148807
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of an antacid on gastrointestinal absorption of theophylline.
    Arnold LA; Spurbeck GH; Shelver WH; Henderson WM
    Am J Hosp Pharm; 1979 Aug; 36(8):1059-62. PubMed ID: 484565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.